Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$64.68M+15.0%$61.86M+10.2%$59.4M+2.8%$56.4M-27.4%$56.24M-29.7%
$22.35M+18.6%$20.92M+0.2%$17.72M-15.2%$17.25M-21.7%$18.85M-18.9%
$42.33M+13.2%$40.93M+16.1%$41.68M+13.0%$39.15M-29.7%$37.39M-34.1%
65.4%-1.0pp66.2%+3.4pp70.2%+6.3pp69.4%-2.2pp66.5%-4.4pp
$480K-95.1%$544K-95.1%$1.1M-91.2%$2.01M-85.0%
$43.91M+3.7%$44.37M+10.4%$44.57M+11.5%$43.91M+18.0%$42.35M+8.5%
$71.02M+12.5%$70.03M+0.3%$64.89M-14.4%$63.26M-16.3%$63.15M-23.5%
-$6.34M-$8.17M
-9.8%-13.2%
$3.7M+21.6%$3.7M+37.0%$3.6M+90.0%$3.42M+144%$3.04M+90.7%
-$3.19M-140%-$3.2M-243%-$3.05M-980%-$1.76M-53.2%-$1.33M+6.5%
-$9.53M-$11.37M
-$9.59M-$11.43M
-14.8%-18.5%
-$0.37-$0.47
-$2.02M-$3.91M
-3.1%-6.3%
-$6.34M-$8.17M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Journey Medical Corporation's revenue?
Journey Medical Corporation (DERM) generated $64.7M in revenue over the trailing twelve months, up 15.0% year over year.
Is Journey Medical Corporation profitable?
Journey Medical Corporation is not currently profitable: it reported a net loss of $9.6M over the trailing twelve months, a -14.8% net margin.
What are Journey Medical Corporation's profit margins?
Gross margin is 65.4% and operating margin is -9.8%, with a -14.8% net margin.
What is Journey Medical Corporation's earnings per share?
Journey Medical Corporation's diluted EPS over the trailing twelve months is $-0.37.
Where does Journey Medical Corporation's income statement data come from?
Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.